مباشر

BioPharma DiveLilly data point to ‘maintenance’ strategies for GLP-1 weight loss FierceBiotechHumacyte cuts spending, staff as it seeks to boost sluggish sales for its off-the-shelf artery implant FierceBiotechWith $1B Novo deal and diabetes ambitions undimmed, Lexicon is in ‘good shape to go crazy’Endpoints NewsPost-Hoc: Why FDA Commissioner Marty Makary was ousted FierceBiotechFosun pays $60M for option on AriBio’s phase 3 Alzheimer’s asset BioPharma DiveAssertio accepts new buyout bid; AI biotech Isomorphic banks $2B LabCorpLabcorp stock (US50540R4092): Enhances Partnership with Epic for Lab Services - AD HOC NEWS Eli LillyEli Lilly shows sustained weight loss in new pill study - medwatch.com CatalentElpida Therapeutics, Catalent Partner for Late-Phase AAV Manufacturing - Contract Pharma Endpoints NewsBehind Galapagos’ transformation into Lakefront Biotherapeutics FierceBiotechValneva to lay off up to 15% of workforce in face of ‘adverse trend’ in travel vaccines PharmaVoiceIndia’s pharma industry is going global. But can it catch up to China?

FierceBiotech ١٣ مايو ٢٠٢٦

Medtronic to shutter Santa Rosa plant as it restructures cardio vascular unit

Medtronic will shutter its Santa Rosa facility that produces coronary stents and other heart-related products over the next two years as the device maker also l...

Medtronic will shutter its Santa Rosa facility that produces coronary stents and other heart-related products over the next two years as the device maker also looks to restructure its cardio business.